Patented Topical & Transdermal Drug Delivery Systems and Therapeutics

CellMedics, Inc. (Las Vegas, NV) is a specialty biopharmaceutical company that has developed multi-patented topical and transdermal drug delivery systems and therapeutics. The CellMedics Deep Tissue Delivery System™ is a vehicle cream designed to transport hard-to-deliver drug molecules including proteins & peptides into and through the skin to target tissue. Drug delivery can be targeted locally into site-specific tissues or systemically into the bloodstream. Any drug (including generics) administered in CellMedics' drug delivery cream is a patented formulation. It's a disruptive platform technology that's been awarded composition of matter patents that meet the U.S. Patent and Trademak Office's evidence-based requirements of being new, novel and non-obvious chemical compositions that are an improvement over prior technology. More effective drug delivery results in a greater therapeutic effect. Preclinical studies suggest that CellMedics^® patented topical and transdermal cream formulations may be safer and more effective than oral dosing by pills for many drugs and significantly more efficacious (bioavailable) than conventional creams, gels and patches. This new drug delivery technology has the potential to be the preferred method for the administration of many drugs; particularly those that cause adverse effects in the stomach and liver when taken orally. CellMedics is focused on developing licensing partnerships with global consumer healthcare and pharmaceutical companies as well as direct selling our own proprietary topical and transdermal cream therapeutics.